Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
banner
moniquewasunna.bsky.social
Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
@moniquewasunna.bsky.social
@dndi Africa Ambassador, Former East Africa Director, Leishmaniasis East Africa Platform (LEAP) founder. Passionate about finding treatments for #NTD patients.
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
✨We wish you a joyful holiday season & happy 2026! We deeply appreciate the colleagues, supporters, partners, & friends who have joined us in our journey putting equity at the heart of medical innovation.

We look forward to continuing to innovate together in the year to come!
December 19, 2025 at 11:22 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
How does treatment for #PKDL affect the #leishmaniasis parasite and the human immune system? We need to know so that we can get the dosing right. Read more here doi.org/10.1002/cpt....
Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post‐Kala‐Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
Post-kala-azar dermal leishmaniasis (PKDL) involves a high macrophage burden in which the Leishmania parasites reside. Liposomal amphotericin B (LAmB) plays a key role in the treatment of PKDL. The m...
doi.org
December 19, 2025 at 2:26 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
To learn about the global burden of cryptococcal disease, limitations of currently available treatments, attributes of much-needed novel treatments, and potential drug discovery and development pathways, click here www.journalofinfection.com/article/S016...
Target product profile and discovery and development path for novel cryptococcal disease treatments
Cryptococcus neoformans and Cryptococcus gattii are World Health Organization critical and medium priority pathogens, respectively. These mainly impact people with human immunodeficiency virus residin...
www.journalofinfection.com
December 19, 2025 at 2:49 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
✨ As the year draws to a close, we would like to thank our partners, researchers and stakeholders for your trust, collaboration and shared commitment to advancing global health.

From all of us at Global Health EDCTP3, we wish you a peaceful festive season and a bright start to 2026.
December 19, 2025 at 3:06 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Pitch your project ideas and connect on the #InfoDay2026 networking platform

Post opportunities to get noticed:
🔹 Services
🔹 Project cooperation
🔹 Expertise

Register: www.b2match.com/e/info-day-a...
December 16, 2025 at 4:32 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
We’re pleased to introduce the 2025-2026 cohort of the #WithoutBordersMediaFellowship! This year, the fellows will spotlight #NTDs & gender-responsive R&D, along with the systemic barriers shaping health outcomes in #SouthAsia.

tinyurl.com/3x74zku3 @gardp.bsky.social

#beatNTDs
December 16, 2025 at 2:31 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
🚨 Call for #PhD candidates

#PhD position in ecology and improved surveillance of Simulium vectors of human Onchocerciasis, hosted by @cirad.bsky.social

📍 Montpellier, France and Yaoundé, Cameroon
🗓️ Deadline: 24 Dec 2025

Apply: umr-intertryp.cirad.fr/en/actualite...

#CapacityStrengthening
December 12, 2025 at 2:42 PM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
🎓Free self-paced course on Research Communication by TDR

Learn to turn complex evidence into clear and persuasive messages that drive action.

📅 Available until 31 December 2026
⏱️ 2-3 hours
🖥️ Online

👉 Enrol: tdrmooc.org/courses/cour...
December 8, 2025 at 7:52 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Kenya’s health workforce must catch up with the rising tide of cardiometabolic diseases.

Our new issue briefly outlines how stronger training, updated curriculum, and better infrastructure can equip health professionals to deliver quality CMD care.

🔗 buff.ly/NCfrt44

#APHRCResearch #IamAPHRC
Strengthening Capacity of Health Professionals to Address Kenya’s Rising Burden of Cardiometabolic Diseases - APHRC
Executive Summary Limited faculty capacity, outdated curricula, inadequate research infrastructure, and weak knowledge translation mechanisms are undermining the ability of [...]Read More...
buff.ly
December 8, 2025 at 7:55 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Join us Nov 6 (3–4:30 PM EAT) for a webinar on bridging the gap between research & policy for #NTDs amid shifting funding.

👉 Register here: us02web.zoom.us/webinar/regi...
October 31, 2025 at 10:39 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Once a major public health threat, kala-azar is now close to elimination in South Asia.

At #WHOSEARO78, we co-hosted a high-level event with the Govt of India, the Govt of Nepal, WHO South-East Asia, and Gates Foundation India to mark 20 years of the Regional Kala-azar Elimination Initiative.
October 16, 2025 at 11:38 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Join us at the @sciencebusiness.net conference 'Healthy competition: Can Europe regain its global edge in life sciences?'

📆 Thursday, 16 October, 11:00-11:45
📍 Brussels and online

Register: sciencebusiness.net/events/healt...
Healthy competition: Can Europe regain its global edge in life sciences?
Since the publication of Ursula von der Leyen’s political guidelines in July 2024, increasing competitiveness has become a mantra across the EU policy landscape, along with ‘closing the gap’ with the ...
sciencebusiness.net
October 13, 2025 at 10:26 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
🎬 Meet Henry — The Boy Who Beat The Sandfly.

A powerful story of resilience, hope, and the urgent need for better treatments for children with #VisceralLeishmaniasis.

📽️ Trailer out now. Full film coming soon!

#ZeroLeish #NNN2025 #GlobalHealth #KalaAzar
October 6, 2025 at 7:28 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
At #ScienceSummit #UNGA80, we chaired 'Partnering through Science: Africa–Europe Cooperation for Health #Security in a Changing #Climate.'

We also met key figures from Novo Nordisk and Novartis and are excited to turn these insights into action!
October 3, 2025 at 7:19 AM
Reposted by Dr Monique Wasunna, MBChB, MSc, PHD, DTM&H
Chrispin Owaga, new #NNN2025 chair for the #schistosomiasis working group, calls for a strategy shift: with global funding landscapes changing and drug donation resources dwindling, innovation in diagnostics, treatments & vaccines is more critical than ever. #beatNTDs
October 1, 2025 at 3:35 PM